Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
about
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmDiuretics for heart failureAngiotensin receptor blockers for heart failureDiuretics for heart failureMedical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancerMedical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancerDiuretics for heart failureDevices in the management of advanced, chronic heart failureInformative noncompliance in endpoint trialsDose response of ACE inhibitors: implications of the SECURE trialThe Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialInfluence of diabetes mellitus on heart failure risk and outcomeManagement of congestive heart failure: a gender gap may still exist. Observations from a contemporary cohortCritical Questions about PARADIGM-HF and the FutureHeart Failure: Diagnosis, Management and UtilizationPrevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyPrognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney diseaseStage B: what is the evidence for treatment of asymptomatic left ventricular dysfunction?Patient selection in heart failure with preserved ejection fraction clinical trialsAssociation of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of AtherosclerosisHeart Failure: a Major Cardiovascular Complication of Diabetes MellitusSpotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to datePresent and future pharmacotherapeutic agents in heart failure: an evolving paradigmLong term side effects of adjuvant chemotherapy in patients with early breast cancerClinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEMTrends in the care of patients with acute myocardial infarction at a university-affiliated Veterans Affairs Medical CenterAntiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmOptimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care settingPatterns of pharmacotherapy in patients hospitalised for congestive heart failureViral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and managementLong-term use of secondary prevention medications for heart failure in Western Australia: a protocol for a population-based cohort studyMeta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failureNovel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-AnalysisMedical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.Using recurrent neural network models for early detection of heart failure onset.Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.Myocardial Contrast Echocardiography in the Evaluation of Hypertensive Heart Disease.Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.
P2860
Q24185800-8C1850BD-88C9-4FF2-9824-E328736B1E3AQ24185944-E67601B6-C0FE-4C66-8E80-CF56C5C9AE2EQ24199125-2A91F3BE-284C-43B2-BE71-98590FAA17AAQ24203661-DAFA74C1-1159-42E8-A830-830EA4F02BF3Q24234511-7B7EB5E3-84A0-4FC8-BE71-873A2B315794Q24241097-89C94DD6-7B6B-45C9-BA93-E61B6704F46EQ24244710-F5E9328F-2E25-4F34-A047-04B19AFE84F0Q24630052-77FDA90D-596F-4C23-8569-1E493B8D6F27Q24791524-09E53064-482D-4E7B-B812-B4F2C4BEC534Q24793271-4C641960-232B-40E3-A0CD-FCA8BCDC57CAQ24793456-2982FF33-7203-4F48-BDAA-01BBA53DE755Q24800363-8AE4D695-2EA8-40EE-B7AC-9CDAD04EA1EFQ24800931-2F16D3D9-D489-41BD-8F05-39A42483069BQ26741029-D64F0B37-9BB6-4033-81AF-34863A45E87AQ26745543-D338C2CD-B3C4-4ADA-82A4-D21E9E9AF97CQ26768272-EC9E8EFC-FB53-4B27-9A0C-62F7F531F0C6Q26796261-B140B498-CC30-4B8C-B132-197C19868F36Q26801625-FE8E65A9-2AA7-4FA2-9A77-B0FE28CC3FD2Q26853063-71808E42-0FAE-496E-83D4-0AF4877BBF3BQ27015845-079E910F-27EB-4B2F-9BD4-D02FB26C9F95Q27332462-7D9EBF74-129C-440F-9828-06FDBD46B534Q28066310-D0790BBF-5D44-4217-BF7F-7BBD9D895C7FQ28070064-75092657-5D26-4B49-9C7A-31CCA82A233BQ28077186-B7C68656-92A7-430F-9EF1-B4C7C03B32E6Q28083233-7963C1E0-D1A3-4932-8F09-207F9EEEEDFEQ28166022-2FB624E5-B369-4E96-A322-04A277330693Q28174000-3D6EC0E7-5557-4948-AF9C-C00A319FDBD2Q28191116-CA095295-5E71-4068-BE18-573844D411EAQ28193213-BD68E2EC-F6E1-4F5D-B958-5083E67EDE9FQ28195422-7F8051BC-F80C-456C-8B8F-6F86FEF98B6DQ28345278-F0385E3B-64BB-4244-8AEA-5E006E4D59D0Q28591667-4F0BBE4F-34CE-4F48-9643-4EA3E52CED74Q28748219-5E20BF1B-7AEE-4C7F-B255-C2F0A49C1C65Q30235583-ED8B1AA0-7F04-44D3-BFEA-11DF85900ECAQ30239022-5B174F1D-EE67-436F-9433-A5C36F849C0BQ30248340-5BEBBC27-70F0-4AC7-B4D6-6B021924E6DCQ30358244-AB8711AD-6F9D-4228-81C7-7DD1735F2C03Q30359729-182A8F41-7321-4B9E-9C08-4EA2C699A912Q30360279-C32F2CE7-5A61-42F2-9DC4-FB6834E5D707Q30381121-4091CF06-EFD1-47D1-82E1-295D5D487897
P2860
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Effect of enalapril on mortali ...... entricular ejection fractions.
@en
Effect of enalapril on mortali ...... entricular ejection fractions.
@nl
type
label
Effect of enalapril on mortali ...... entricular ejection fractions.
@en
Effect of enalapril on mortali ...... entricular ejection fractions.
@nl
prefLabel
Effect of enalapril on mortali ...... entricular ejection fractions.
@en
Effect of enalapril on mortali ...... entricular ejection fractions.
@nl
P2093
P1476
Effect of enalapril on mortali ...... entricular ejection fractions.
@en
P2093
P304
P356
10.1056/NEJM199209033271003
P407
P577
1992-09-01T00:00:00Z